Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Common Equity (2023 - 2025)

Guardian Pharmacy Services' Common Equity history spans 3 years, with the latest figure at $217.9 million for Q4 2025.

  • For Q4 2025, Common Equity rose 45.31% year-over-year to $217.9 million; the TTM value through Dec 2025 reached $217.9 million, up 45.31%, while the annual FY2025 figure was $217.9 million, 45.31% up from the prior year.
  • Common Equity for Q4 2025 was $217.9 million at Guardian Pharmacy Services, up from $195.5 million in the prior quarter.
  • Across five years, Common Equity topped out at $217.9 million in Q4 2025 and bottomed at $56.6 million in Q1 2024.
  • The 3-year median for Common Equity is $150.0 million (2024), against an average of $134.9 million.
  • The largest YoY upside for Common Equity was 214.04% in 2025 against a maximum downside of 45.31% in 2025.
  • A 3-year view of Common Equity shows it stood at $59.9 million in 2023, then soared by 150.55% to $150.0 million in 2024, then skyrocketed by 45.31% to $217.9 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Common Equity are $217.9 million (Q4 2025), $195.5 million (Q3 2025), and $179.7 million (Q2 2025).